July 5, 2024
Home Fireside chat
Investors

Cellebrite Announces Participation in Upcoming Investor Conferences

  • May 16, 2024

Cellebrite DI Ltd TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 16, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company plans to participate in the following investor conferences in May and June: About Cellebrite Cellebrite’s (Nasdaq: CLBT)

Read More
Investors

Spruce Biosciences to Participate in May Investor Conferences

  • May 1, 2024

SOUTH SAN FRANCISCO, Calif., May 01, 2024–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in two upcoming investor conferences taking place in May. The JMP

Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline